ARTICLE | Company News
Life Science Pharmaceuticals, Abbott deal
November 24, 2008 8:00 AM UTC
Life Science granted Abbott exclusive, worldwide rights to develop and commercialize ch806 to treat cancer and other indications, including psoriasis. Abbott did not disclose its plans for the chimer...